Presented by Ryan Kirk, PsyD, MSW, HSPP, Katie Kirk, PsyD, LAC
Course: #1589Level: Intermediate2.13 Hours
ASWB ACE/2.25 Ethics; CA (CAADE)/2.0; CA (CADTP)/2.0; CA (CCAPP-EI)/2.0; CE Broker/2.0 Ethics, Supervision, Diagnosis And Treatment Of Mental Health Disorders, CE Broker #20-1165862; CE Hours/2.0; CT (CCB)/2.0; GA (ADACBGA)/2.0; HI (ADAD)/2.0; IACET/0.2; IL (ICB)/2.0 , Counselor I, Counselor II, Preventionist I, Preventionist II, CARS I, CARS II, CODP I, CODP II, PCGC II, CCJP II, CAAP I, CAAP II, CRSS I, CRSS II, CPRS I, CPRS II, MAATP I, MAATP II, CFPP II, CVSS II; IL (MFT CE Sponsor)/2.0; MI (MCBAP)/2.0 Specific, Treatment Ethics; MO (MCB)/2.0; NAADAC/2.0 Counseling Services, Documentation And Record-keeping, Legal Ethical And Professional Development; NBCC CE Hours/2.0; NY-Contact Hours/2.0 Self-Study; OH (OCDP)/2.0 C6, C9; OK (LPC/LMFT)/2.0; OK (OBLADC)/2.0
This course empowers behavioral health clinicians with the necessary skills and ethical competencies for delivering integrated, evidence-based addiction care to patients undergoing medication-assisted treatment (MAT). A focus on confidentiality, MAT and general ethics including HIPAA and CFR 42, and supervision standards are addressed. Participants will explore substance use disorders from a neuroscience perspective, develop counseling best practices within interdisciplinary MAT settings, and cover topics ranging from harm reduction strategies to documentation of medical necessity, aiming to enhance support for individuals managing addiction and dual diagnoses.